E. Boven

Treatment of High-grade Non–muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial “NIMBUS”

Marc‐Oliver Grimm, Antoine G. van der Heijden, Marc Colombel et al. · European Urology · 2020 · 133 citations

Medicine, Oncology, Urology +8

EO9: A novel bioreductive alkylating indoloquinone with preferential solid tumour activity and lack of bone marrow toxicity in preclinical models

Hans R. Hendriks, P. E. Pizao, Dan Berger et al. · European Journal of Cancer · 1993 · 104 citations · Full text

Medicine, Oncology, Pharmacology +7

Phase II Marker Lesion Study With Intravesical Instillation of Apaziquone for Superficial Bladder Cancer: Toxicity and Marker Response

Antoine G. van der Heijden, Paula M.J. Moonen, Erik B. Cornel et al. · The Journal of Urology · 2006 · 71 citations

Medicine, Oncology, Pharmacology +15

Preclinical phase II studies in human tumor xenografts: A European multicenter follow-up study

Simon P. Langdon, Hans R. Hendriks, Boudewijn J.M. Braakhuis et al. · Annals of Oncology · 1994 · 67 citations

Medicine, Biomedical Sciences, Oncology +4

Discrepancy between clinical staging through bimanual palpation and pathological staging after cystectomy

Martine Ploeg, Lambertus A. Kiemeney, Geert A.H.J. Smits et al. · Urologic Oncology Seminars and Original Investigations · 2010 · 44 citations

Medicine, Pathology, Surgery +9